A new trading day began on Monday, with ProQR Therapeutics N.V (NASDAQ: PRQR) stock price down -3.17% from the previous day of trading, before settling in for the closing price of $2.21. PRQR’s price has ranged from $1.07 to $3.10 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 25.70% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -29.35%. With a float of $70.02 million, this company’s outstanding shares have now reached $105.35 million.
ProQR Therapeutics N.V (PRQR) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ProQR Therapeutics N.V is 33.45%, while institutional ownership is 35.10%.
ProQR Therapeutics N.V (PRQR) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.1 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -29.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -21.57% during the next five years compared to 25.70% growth over the previous five years of trading.
ProQR Therapeutics N.V (NASDAQ: PRQR) Trading Performance Indicators
Here are ProQR Therapeutics N.V’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of ProQR Therapeutics N.V (PRQR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.55 million. That was better than the volume of 0.45 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 22.89%.
During the past 100 days, ProQR Therapeutics N.V’s (PRQR) raw stochastic average was set at 26.15%, which indicates a significant decrease from 40.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was higher than the 0.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.36, while its 200-day Moving Average is $2.02. However, in the short run, ProQR Therapeutics N.V’s stock first resistance to watch stands at $2.22. Second resistance stands at $2.30. The third major resistance level sits at $2.37. If the price goes on to break the first support level at $2.07, it is likely to go to the next support level at $2.00. Assuming the price breaks the second support level, the third support level stands at $1.92.
ProQR Therapeutics N.V (NASDAQ: PRQR) Key Stats
With a market capitalization of 225.15 million, the company has a total of 105,213K Shares Outstanding. Currently, annual sales are 20,460 K while annual income is -30,040 K. The company’s previous quarter sales were 3,370 K while its latest quarter income was -12,860 K.
